The conference will showcase the most innovative approaches to fighting AMR.
We cordially invite scientists from SMEs and academic institutions to submit an abstract for a poster presentation addressing the following AMR topics:
Traditional and non-traditional therapeutic approaches to tackle AMR in humans and animals
Technologies enabling antimicrobial vaccine and drug development (i.e. preclinical platforms, drug screening technologies, techniques for resistance testing, clinical trial design, bioinformatic tools)
Diagnostic AMR innovations for humans and animals
Other AMR topics relevant for drug and diagnostics development
The abstract text may not be longer than a maximum of 350 words. A maximum of one picture, graph or table can be included per abstract.
You will receive a confirmation email after submission. Changes in the abstract are not possible after submission.
The deadline for abstract submission is now extended to 31st January 2022.
Abstracts will be reviewed by a scientific committee. The committee will assess abstracts with regard to scientific excellence and relevance and will nominate poster presentations. You will be notified about the status/outcome of your poster application by beginning of February 2022.
There is no fee for the poster presentation. However, the presenting author must be a registered participant. Please note that the presenting author is not automatically registered by submitting an abstract. Regular registration is required (special rate for academia of CHF 430,00 + 7.7% Swiss VAT).
If you have any questions, please do not hesitate to contact us at